Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies.

Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies.

Show other versions (1)

In addition to statin therapy, Ezetimibe, a non-statin lipid-modifying agent, is increasingly used to reduce low-density lipoprotein cholesterol and atherosclerotic cardiovascular disease risk. Literature suggests the clinical effectiveness of Ezetimibe plus statin (EPS) therapy; however, primary ev...

Full description

Bibliographic Details
Main Authors:	Akhil Sasidharan, Bhavani Shankara Bagepally, S Sajith Kumar, Kayala Venkata Jagadeesh, Meenakumari Natarajan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0264563

Similar Items

Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies
by: Akhil Sasidharan, et al.
Published: (2022-01-01)

Incremental net benefit of cholecystectomy compared with alternative treatments in people with gallstones or cholecystitis: a systematic review and meta-analysis of cost–utility studies
by: Bhavani Shankara Bagepally, et al.
Published: (2022-01-01)

Is State-Wise Healthcare Budget Allocation Consistent With the Disease Burden in India? A Quinquennial Account (2015–2019)
by: Bhavani Shankara Bagepally, et al.
Published: (2022-06-01)

Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies
by: S. Sajith Kumar, et al.
Published: (2022-12-01)

Cost-effectiveness of surgical mask, N-95 respirator, hand-hygiene and surgical mask with hand hygiene in the prevention of COVID-19: Cost effectiveness analysis from Indian context
by: Bhavani Shankara Bagepally, et al.
Published: (2021-04-01)

Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
by: Na-Qiong Wu, et al.
Published: (2018-11-01)

Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
by: Mihaylova, B, et al.
Published: (2019)

Household catastrophic health expenditures for rheumatoid arthritis: a single centre study from South India
by: Bhavani Shankara Bagepally, et al.
Published: (2023-09-01)

Health-related quality of life among COVID-19 individuals: A cross-sectional study in Tamil Nadu, India
by: Suganya Barani, et al.
Published: (2022-01-01)

A perspective on trends in air pollution attributed disease burden in India-Authors' reply
by: S Sajith Kumar, et al.
Published: (2022-12-01)

Air pollution attributed disease burden and economic growth in India: Estimating trends and inequality between states
by: Sajith Kumar S, et al.
Published: (2022-12-01)

Comparative Efficacy and Safety of Statin Monotherapy and Statin plus Ezetimibe Combination in a Real-World Setting
by: Marat V. Ezhov, et al.
Published: (2023-11-01)

Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients
by: Lin Jianxin, et al.
Published: (2011-08-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

Electronic versus paper-based data collection for conducting health-care research: A cost-comparison analysis
by: Sirshendu Chaudhuri, et al.
Published: (2022-01-01)

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
by: Ian Hamilton-Craig, et al.
Published: (2010-11-01)

The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia
by: Livio Dei Cas, et al.
Published: (2009-08-01)

Combination therapy in cholesterol reduction: focus on ezetimibe and statins
by: Liliana Grigore, et al.
Published: (2008-04-01)

Does the addition of ezetimibe to statins reduce cardiovascular risk?
by: Francisca I Araya, et al.
Published: (2016-12-01)

Statin and Ezetimibe Combination Therapy Decreases Mean Platelet Volume Compared to Statin Monotherapy
by: Jun-beom Lee, et al.
Published: (2017-01-01)

Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia
by: Jeongmin Lee, et al.
Published: (2023-11-01)

Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach
by: Bagepally BS, et al.
Published: (2024-03-01)

Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial
by: Yu Chih-Chieh, et al.
Published: (2012-05-01)

45. Ezetimibe and statins yields on silent holter ambulatory myocardial ischemia
by: W. Kadro
Published: (2016-07-01)

Household catastrophic health expenditure for COVID-19 during March-August 2021, in South India: a cross-sectional study
by: Elumalai Rajalakshmi, et al.
Published: (2023-01-01)

Association between chronotype and cardio-vascular disease risk factors: A systematic review and meta-analysis
by: Ditipriya Bhar, et al.
Published: (2022-07-01)

Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
by: Natalie C. Ward, et al.
Published: (2022-11-01)

Current Perspectives on the Attainment of Lipid Modification Goals Relating to the Use of Statins and Ezetimibe for the Prevention of Cardiovascular Disease in the United Kingdom
by: Reynolds TM, et al.
Published: (2021-05-01)

Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV
by: Johns Kevin W, et al.
Published: (2007-06-01)

Impact of combination therapy with statin and ezetimibe on secondary prevention for post-acute myocardial infarction patients in the statin era
by: Soichiro Ebisawa, et al.
Published: (2015-09-01)

Intensive statin versus low-dose statin + ezetimibe treatment for fibrous cap thickness of coronary vulnerable plaques
by: Pei-Na Meng, et al.
Published: (2020-10-01)

Effect of plant sterols compared with ezetimibe on oxidative stress in patients treated with statins
by: Adriana Bertolami, et al.
Published: (2014-09-01)

Ezetimibe - A clinically effective and a cost-effective treatment option for dyslipidaemia
by: Croom, K, et al.
Published: (2008)

Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis
by: Byung Gyu Kim, et al.
Published: (2023-11-01)

Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
by: Gounari, P, et al.
Published: (2010)

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
by: Manon C. Stam‐Slob, et al.
Published: (2017-02-01)

The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function
by: Assunta Di Costanzo, et al.
Published: (2023-07-01)

The cost-effectiveness and cost-utility of statin drug for the treatment of patients with cardiovascular disease, a systematic review
by: Mahmoud Eisavi, et al.
Published: (2021-01-01)

The efficacy and safety of statin in combination with ezetimibe compared with double-dose statin in patients with high cardiovascular risk: A meta-analysis
by: Yunyun Zhu, et al.
Published: (2020-05-01)

A report of successful management with simvastatin plus ezetimibe in alopecia areata
by: Javier Arellano, et al.
Published: (2020-11-01)